stepdown.mams | R Documentation |
The function determines stopping boundaries for all intersection hypothesis tests in a multi-arm multi-stage study, given the amount of alpha (familywise error rate) to be spent at each analysis.
stepdown.mams(nMat=matrix(c(10, 20), nrow=2, ncol=4),
alpha.star=c(0.01, 0.025), lb=0,
selection="all.promising")
nMat |
Matrix containing the cumulative sample sizes in each treatment arm columns: control, trt 1, ..., trt K), at each analysis (rows). The number of analyses must be either 2 or 3 (default=matrix(c(10, 20), nrow=2, ncol=4)). |
alpha.star |
Cumulative familywise error rate to be spent at each analysis (default=c(0.01, 0.025)). |
lb |
Fixed lower boundary (default=0). |
selection |
How are treatments selected for the next stage? Using the default "all.promising" method, all treatments with a test statistic exceeding the lower boundary are taken forward to the next stage. If "select.best", only the treatment with the largest statistic may be selected for future stages. (default="all.promising"). |
The function implements the methods described in Magirr et al (2014) to find individual boundaries for all intersection hypotheses.
An object of the class MAMS.stepdown containing the following
components:
l |
Lower boundaries. |
u |
Upper boundaries. |
nMat |
Cumulative sample sizes on each treatment arm. |
K |
Number of experimental treatments. |
J |
Number of stages in the trial. |
alpha.star |
Cumulative familywise error rate spent at each analysis. |
selection |
Pre-specified method of treatment selection. |
zscores |
A list containing the observed test statistics at analyses so far (at the design stage this is NULL). |
selected.trts |
A list containing the treatments selected for each stage. |
Dominic Magirr
Jaki T., Pallmann P. and Magirr D. (2019), The R Package MAMS for Designing Multi-Arm Multi-Stage Clinical Trials, Journal of Statistical Software, 88(4), 1-25. Link: doi:10.18637/jss.v088.i04
Magirr D., Jaki T. and Whitehead J. (2012), A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection, Biometrika, 99(2), 494-501. Link: doi:10.1093/biomet/ass002
Magirr D., Stallard N. and Jaki T. (2014), Flexible sequential designs for multi-arm clinical trials, Statistics in Medicine, 33(19), 3269-3279. Link: doi:10.1002/sim.6183
Stallard N. and Todd S. (2003), Sequential designs for phase III clinical trials incorporating treatment selection, Statistics in Medicine, 22(5), 689-703.
# Note that some of these examples may take a few minutes to run
# 2-stage 3-treatments versus control design, all promising treatments
# are selected:
stepdown.mams(nMat=matrix(c(10, 20), nrow=2, ncol=4),
alpha.star=c(0.01, 0.05), lb=0,
selection="all.promising")
# select the best treatment after the first stage:
stepdown.mams(nMat=matrix(c(10, 20), nrow=2, ncol=4),
alpha.star=c(0.01, 0.05), lb=0,
selection="select.best")
# 3 stages and unequal randomization:
stepdown.mams(nMat=matrix(c(20, 40, 60, rep(c(10, 20, 30), 3)),
nrow=3, ncol=4),
alpha.star=c(0.01, 0.025, 0.05), lb=c(0, 0.75),
selection="all.promising")
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.